Copyright Reports & Markets. All rights reserved.

Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Research Report 2021

Buy now

1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Overview

  • 1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM) System for Diabetes Management
  • 1.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Type
    • 1.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Wearable
    • 1.2.3 Implantable
  • 1.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Application
    • 1.3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals & Clinics
    • 1.3.3 Homecare Settings
  • 1.4 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Estimates and Forecasts
    • 1.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2016-2027
    • 1.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2016-2027
    • 1.4.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region: 2016 Versus 2021 Versus 2027

2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competition by Manufacturers

  • 2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Sites, Area Served, Product Type
  • 2.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competitive Situation and Trends
    • 2.5.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) System for Diabetes Management Players Market Share by Revenue
    • 2.5.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Retrospective Market Scenario by Region

  • 3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
    • 3.3.1 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
    • 3.3.2 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
    • 3.4.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
    • 3.4.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region
    • 3.5.2 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
    • 3.6.1 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
    • 3.6.2 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
    • 3.7.2 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Historic Market Analysis by Type

  • 4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2016-2021)
  • 4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2016-2021)
  • 4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Type (2016-2021)

5 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Historic Market Analysis by Application

  • 5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2016-2021)
  • 5.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2016-2021)
  • 5.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Abbott Diabetes Care Inc.
    • 6.1.1 Abbott Diabetes Care Inc. Corporation Information
    • 6.1.2 Abbott Diabetes Care Inc. Description and Business Overview
    • 6.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.1.5 Abbott Diabetes Care Inc. Recent Developments/Updates
  • 6.2 Dexcom
    • 6.2.1 Dexcom Corporation Information
    • 6.2.2 Dexcom Description and Business Overview
    • 6.2.3 Dexcom Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Dexcom Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.2.5 Dexcom Recent Developments/Updates
  • 6.3 Medtronic
    • 6.3.1 Medtronic Corporation Information
    • 6.3.2 Medtronic Description and Business Overview
    • 6.3.3 Medtronic Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Medtronic Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.3.5 Medtronic Recent Developments/Updates
  • 6.4 Senseonics Holdings
    • 6.4.1 Senseonics Holdings Corporation Information
    • 6.4.2 Senseonics Holdings Description and Business Overview
    • 6.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Senseonics Holdings Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.4.5 Senseonics Holdings Recent Developments/Updates
  • 6.5 GlySens Incorporated
    • 6.5.1 GlySens Incorporated Corporation Information
    • 6.5.2 GlySens Incorporated Description and Business Overview
    • 6.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GlySens Incorporated Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.5.5 GlySens Incorporated Recent Developments/Updates
  • 6.6 Meiqi Medical Equipment
    • 6.6.1 Meiqi Medical Equipment Corporation Information
    • 6.6.2 Meiqi Medical Equipment Description and Business Overview
    • 6.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.6.5 Meiqi Medical Equipment Recent Developments/Updates
  • 6.7 San Meditech
    • 6.6.1 San Meditech Corporation Information
    • 6.6.2 San Meditech Description and Business Overview
    • 6.6.3 San Meditech Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 San Meditech Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
    • 6.7.5 San Meditech Recent Developments/Updates

7 Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Cost Analysis

  • 7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
  • 7.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors List
  • 8.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Customers

9 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Dynamics

  • 9.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Trends
  • 9.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Growth Drivers
  • 9.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Challenges
  • 9.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Restraints

10 Global Market Forecast

  • 10.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Type (2022-2027)
  • 10.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Application (2022-2027)
  • 10.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Wearable
    Implantable

    Segment by Application
    Hospitals & Clinics
    Homecare Settings

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Abbott Diabetes Care Inc.
    Dexcom
    Medtronic
    Senseonics Holdings
    GlySens Incorporated
    Meiqi Medical Equipment
    San Meditech

    Buy now